[spacer image]
BD
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]

Did you know?
[spacer image] BD began manufacturing sterile disposable products in 1961, when it introduced the BD Plastipak™ syringe. Learn more about BD's history » [spacer image]
[spacer image]


Investment Focus
Email Page Print
[spacer image]

The primary mission of BD Ventures is to make investments in companies that match the strategic interests of our parent organization while at the same time achieve superior financial returns by investing in successful companies. 

Investment Parameters

Industry Preferences

Medical Technology, Life Science and Biotechnology

Geographic Preferences

North America and Europe

Funding Stage Preference

Early- and late-stage private companies

Initial Investment Size

Generally, between $500,000 and $5 MM

Syndication Policy

Lead or co-invest as an active or passive participant

Board Seat Policy

Observer rights

Current Areas of Investment Interest

  • Drug and vaccine delivery technologies
  • Infectious disease diagnostics and monitoring
  • Cancer diagnostics and monitoring
  • Diabetes and other auto-immune diseases monitoring and treatment
  • Cell-based therapies and tissue engineering
  • Cell biology research products

 

 

[spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image]